Aspen willing to alter production for Covid-19 needs

The pharmaceutical manufacturer urges people not to hoard cold and flu medications, saying its supply chain is robust

AfroCentric gets boost from trading businesses

Operating profit increases, with the group boosted by its acquisition of pharmaceutical group Activo Health during the period

Ascendis freezes staff levels as it battles crippling debt pile

The group is seeking to save money by limiting staff numbers and travel, as its debt far exceeds its market capitalisation

WATCH: How Netcare has prepared for the Covid-19 outbreak

Netcare Group CEO Richard Friedland talks to Business Day TV about the coronavirus outbreak

WATCH: How Aspen cut its debt

Aspen CEO Stephen Saad talks to Business Day TV about the company’s interim results

Resuming dividend payments on the cards for Aspen Pharmacare

Africa’s largest pharma company is upbeat over progress in cutting debt

Aspen slashes debt after sale of Japanese business

Africa’s biggest drugmaker has over the past year been disposing of noncore assets to manage its debt

Advanced Health sees double-digit patient growth

The day clinic operator says its offering remains competitive when compared to overnight hospitals

WATCH: How Adcock turned a profit despite rising costs

Adcock CEO Andy Hall talks to Business Day TV about the company’s performance

WATCH: What took the shine off Discovery’s profit

Discovery CEO Adrian Gore talks to Business Day TV about the group’s half-year performance

Slow AIDS drug orders and water shortages hit Adcock Ingram

The government AIDS drug orders from the pharmaceutical company have been less than a third of those anticipated

Discovery keeps dividend unchanged despite profits falling by double digits

Low interest rates in the UK have hit the group’s Vitality Life business

Adcock Ingram eyes new products as it battles rising costs

The group managed to grow profit in its half-year to end-December despite rising costs

Promotional campaigns grow Dis-Chem market share

The pharmacy group says that group revenue is up 10% in the 22 weeks to February 2, as it kept prices low and focused on promotions

Discovery says profit will plunge as low UK interest rates hit VitalityLife

Normalised profit at VitalityLife, which provides insurance to the UK market, is expected to fall 145% in the six months to end-December

Discovery loses appeal on basic-care benefits

Regulator opens door for patients to force schemes to fund treatments unavailable in state sector


Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.